Cardiovascular benefits of semaglutide: a systematic review and meta-analysis of randomized controlled trials
{{output}}
Background: Semaglutide, a GLP-1 receptor agonist (GLP-1RA), has shown potential in controlling type 2 diabetes due to their ability to lower blood glucose and improve cardiovascular outcomes. Although semaglutide is the newest G... ...
